AMUBARVIMAB

UNII:	2AD5KH3SE4
Formula:
Preferred Substance Name:	AMUBARVIMAB
GSRS Full Record:	2AD5KH3SE4 i

2509447-07-6
AMUBARVIMAB [INN]
AMUBARVIMAB [USAN]
AMUBARVIMAB [WHO-DD]
BRII196
BRII-196
IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G1-KAPPA,ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) (SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN)); HOMO SAPIENS MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HOMO SAPIENS (1-447) (VH(HOMO SAPIENS (IGHV3-66*01 (96%)-(IGHD)-IGHJ6*01) (8.7.11) (1-117)-HOMO SAPIENS IGHG1*01 (CH2(M22>Y(252), S24>T(254), T26>E(256))) (118-447) (220-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-20*01-IGKJ2*01)(7.3.8) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (226-226'':229-229'')-BISDISULFIDE, PRODUCED IN CHO-K1 CELL LINE, GLYCOFORM ALFA

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

AMUBARVIMAB

Synonyms and Mappings

Resources